Alfuzosin Hydrochloride

Product NDC
84386-153
11-digit product format
843860153
Labeler code
84386
Product ID
84386-153_8811cb59-6826-41d5-ab68-567338a4b883
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Alfuzosin Hydrochloride
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA079060
Marketing category
ANDA
Marketing start
2026-07-01
Substance
ALFUZOSIN HYDROCHLORIDE
Active strength
10 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A079060-001ALFUZOSIN HYDROCHLORIDEALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A079060-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-3084e616aacf4f…
2026-08-18 06:07:402026-07A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-3031067a03dcf5…
2025-08-23 18:47 UTC2025-08A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-306a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-3003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-302680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-305bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-3079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-301e350fbaab3a…
2024-05-31 18:47 UTC2024-05A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-308072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-305c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-305d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-304b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-3074a2ff9319b5…
2022-03-09 01:35 UTC2022-03A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-3087673890dc5c…
2021-03-12 10:30 UTC2021-03A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-305aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-308869cabd3fbd…
2020-11-12 02:37 UTC2020-11A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30c0c555d07b60…
2019-12-14 00:12 UTC2019-12A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-303f01610625f2…
2019-09-15 20:21 UTC2019-09A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30b00525d2431f…
2019-07-19 19:46 UTC2019-07A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-306a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-301c564ffb4f44…
2023-12-20 04:57 UTC2023-12A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-309b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-303f0d92c62455…
2023-05-13 08:27 UTC2023-05A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30053a50430f4f…
2023-01-26 05:58 UTC2023-01A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-303bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-303a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A079060-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-08-30f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A079060-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A079060-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A079060-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A079060-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A079060-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A079060-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A079060-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A079060-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A079060-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A079060-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A079060-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A079060-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A079060-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A079060-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A079060-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A079060-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A079060-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A079060-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A079060-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A079060-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A079060-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A079060-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A079060-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A079060-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A079060-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A079060-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A079060-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A079060-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A079060-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A079060-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A079060-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A079060-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A079060-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A079060-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A079060-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A079060-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A079060-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A079060-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A079060-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A079060-001AB1f41ea6bd6efb…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Alfuzosin Hydrochloride
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ALFUZOSIN HYDROCHLORIDE10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
75046A1XTNInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
861132Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
8811cb59-6826-41d5-ab68-567338a4b883Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Alfuzosin HydrochlorideALFUZOSIN HYDROCHLORIDEAurobindo Pharma Limitedd163369b-e44b-4591-b166-7ddd0c1c13c02026-07-15Warnings, Adverse reactionsExact identifier
application applno (ANDA): 079060
application number: ANDA079060
Alfuzosin HydrochlorideALFUZOSIN HYDROCHLORIDEAurobindo Pharma Limited8811cb59-6826-41d5-ab68-567338a4b8832026-07-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 079060
application number: ANDA079060
ndc (product): 84386-153
Alfuzosin HydrochlorideALFUZOSIN HYDROCHLORIDEBryant Ranch Prepack37e89394-af6e-4700-bfa8-2effba1a286b2026-05-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 079060
application number: ANDA079060
Alfuzosin HydrochlorideALFUZOSIN HYDROCHLORIDERising Pharma Holdings, Inc.43675e9d-a361-4109-9ae1-54d80580fbbd2026-01-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 079060
application number: ANDA079060
Alfuzosin HydrochlorideALFUZOSIN HYDROCHLORIDENorthwind Health Company, LLCf2a530bd-6a86-251d-e053-2995a90adac42025-12-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 079060
application number: ANDA079060

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
84386-153-0184386015301100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84386-153-01) 2026-07-01NoNoCurrent
84386-153-0584386015305500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84386-153-05) 2026-07-01NoNoCurrent
84386-153-308438601533030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84386-153-30) 2026-07-01NoNoCurrent
84386-153-908438601539090 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84386-153-90) 2026-07-01NoNoCurrent
84386-153-99843860153991000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84386-153-99) 2026-07-01NoNoCurrent